Phospho-EPS15 (Tyr849) Antibody

What is the functional significance of EPS15 Tyr849 phosphorylation in cellular processes?

Phosphorylation of EPS15 at tyrosine 849 plays a critical role in receptor-mediated endocytosis, particularly for the epidermal growth factor receptor (EGFR) pathway. Research demonstrates that this phosphorylation event is specifically involved in the internalization of EGFR but not in membrane translocation after EGF treatment or for targeting to coated pits . It represents a key molecular determinant that differentiates ligand-inducible receptor endocytosis from constitutive endocytosis . For example, studies have shown that while EPS15 has a general role in receptor-mediated endocytosis, the phosphorylation at Tyr849 is specifically required for the internalization of the EGFR but not for the transferrin receptor (TfR) .

What are the standard applications for Phospho-EPS15 (Tyr849) antibodies in research?

Phospho-EPS15 (Tyr849) antibodies are validated for multiple research applications:

When selecting applications, researchers should consider that these antibodies are strictly for research use only (RUO) and must not be used in diagnostic or therapeutic applications .

What are the optimal storage and handling conditions for Phospho-EPS15 (Tyr849) antibodies?

For maximum stability and activity retention, Phospho-EPS15 (Tyr849) antibodies should be stored according to these guidelines:

• Store at -20°C for up to 1 year from the date of receipt

• Avoid repeated freeze-thaw cycles to maintain antibody integrity

• Most formulations contain PBS with 50% glycerol, 0.5% BSA, and 0.02% sodium azide at pH 7.4

• Once thawed for use, antibodies can be aliquoted to minimize freeze-thaw cycles

• Typical concentration is 1 mg/mL, allowing for accurate dilution calculations

Proper storage is critical for maintaining specificity for the phosphorylated form of EPS15 over the non-phosphorylated version.

How should experimental conditions be optimized when using Phospho-EPS15 (Tyr849) antibodies in Western blot applications?

To optimize experimental conditions for Western blot detection:

• Sample preparation:

  • Use phosphatase inhibitors in lysis buffers to preserve phosphorylation status

  • Include appropriate positive controls (e.g., EGF or TNF-α stimulated cells)

• Blocking conditions:

  • Use 5% BSA in TBST rather than milk for phospho-specific antibodies

  • Blocking with milk can introduce phosphatases that reduce signal

• Dilution optimization:

  • Start with the recommended 1:1000 dilution and adjust based on signal intensity

  • For weak signals, increase antibody concentration to 1:500

  • For strong or high background signals, further dilute to 1:2000

• Validation methods:

  • Include a phosphopeptide competition assay to confirm specificity

  • Western blot analysis with phosphatase-treated samples as negative controls

  • The lane treated with antigen-specific peptide should show signal elimination

How can Phospho-EPS15 (Tyr849) antibodies be used to investigate the differential regulation of constitutive versus ligand-induced endocytosis?

To investigate differential regulation of endocytosis pathways:

• Comparative endocytosis assays:

  • Design dual-receptor tracking experiments comparing EGFR (ligand-inducible) and TfR (constitutive) internalization

  • Use Phospho-EPS15 (Tyr849) antibodies to monitor phosphorylation status during both processes

  • Correlate phosphorylation levels with internalization rates measured by flow cytometry or imaging

• Phosphorylation-specific dominant negative approach:

  • Express phosphorylation-negative mutants (Y850F in mouse, equivalent to Y849F in human) as demonstrated in research showing these mutants act as dominant negatives specifically for EGFR but not TfR endocytosis

  • Compare with general EPS15 dominant negatives that affect both pathways

• Phosphopeptide competition experiments:

  • Apply phosphopeptides corresponding to the phosphorylated sequence of EPS15 to inhibit EGFR endocytosis

  • This approach helps identify phosphotyrosine-binding proteins that specifically interact with phosphorylated EPS15

Research has demonstrated that tyrosine phosphorylation of EPS15 represents a molecular determinant that distinguishes between constitutive and regulated endocytosis pathways .

What is known about the relationship between EPS15 Tyr849 phosphorylation and other post-translational modifications?

EPS15 undergoes multiple post-translational modifications that interact in complex regulatory networks:

Research approaches to study these relationships include:

• Temporal analysis:

  • Compare phosphorylation kinetics at different sites following receptor stimulation

  • Determine if modifications occur sequentially or simultaneously

• Mutation studies:

  • Create site-specific mutants (e.g., Y849F, S796A) and assess effects on other modifications

  • Evaluate impact on protein function and localization

• Kinase/phosphatase manipulation:

  • Use inhibitors of specific kinases (e.g., p38 inhibitors for Ser796)

  • Correlate with changes in Tyr849 phosphorylation to establish regulatory relationships

What are common challenges when detecting Phospho-EPS15 (Tyr849) and strategies to overcome them?

For challenging samples:

• Use affinity purification techniques to enrich for phosphorylated proteins before analysis

• Consider phosphatase treatment controls to verify phosphorylation-dependent recognition

• Implement quantitative analysis with appropriate normalization to total EPS15 levels

How should researchers validate the specificity of Phospho-EPS15 (Tyr849) antibody signals in their experimental system?

A comprehensive validation approach should include:

• Peptide competition assays:

  • Pre-incubate the antibody with phospho-peptide immunogen

  • Signal should be abolished or significantly reduced compared to antibody alone

  • Include non-phosphorylated peptide control which should not compete

• Phosphatase treatment controls:

  • Treat duplicate samples with lambda phosphatase

  • Signal should disappear in treated samples while total EPS15 remains detectable

• Stimulation-dependent detection:

  • Compare samples from unstimulated cells versus EGF-stimulated cells

  • Phospho-signal should increase after stimulation

• Genetic validation:

  • Use EPS15 knockdown/knockout cells as negative controls

  • Test Y849F mutant expression which should not be detected by the antibody

• Cross-validation with multiple antibodies:

  • Compare results from different antibody clones or sources

  • Results should be consistent across antibodies with the same specificity

How does studying EPS15 Tyr849 phosphorylation contribute to understanding cancer and other diseases?

The study of EPS15 Tyr849 phosphorylation has several disease implications:

• Cancer relevance:

  • EPS15 gene is rearranged with the HRX/ALL/MLL gene in acute myelogenous leukemias

  • Dysregulation of EGFR endocytosis contributes to sustained signaling in multiple cancer types

  • Analyzing Tyr849 phosphorylation patterns may provide insights into cancer cell resistance to EGFR-targeted therapies

• Research applications in disease contexts:

  • Monitor EPS15 phosphorylation as a biomarker for EGFR pathway activation

  • Study correlation between phosphorylation levels and cancer progression

  • Investigate the effect of clinically relevant EGFR mutations on EPS15 phosphorylation and function

• Therapeutic implications:

  • Develop strategies to modulate receptor endocytosis by targeting this phosphorylation event

  • Study how existing therapies affect EPS15 phosphorylation as a mechanism of action or resistance

Research methodologies should incorporate patient-derived samples or relevant disease models to maximize translational relevance when studying this phosphorylation event.

What are emerging research directions involving Phospho-EPS15 (Tyr849) detection and analysis?

Cutting-edge research areas include:

• Integration with systems biology approaches:

  • Phosphoproteomics analysis to place Tyr849 phosphorylation in broader signaling networks

  • Mathematical modeling of how phosphorylation timing affects endocytic trafficking kinetics

  • Multi-omics integration to correlate phosphorylation with transcriptional and metabolic changes

• Advanced imaging techniques:

  • Super-resolution microscopy to visualize phospho-EPS15 localization at endocytic sites

  • Live-cell biosensors for real-time monitoring of phosphorylation dynamics

  • Correlative light and electron microscopy to connect phosphorylation status with ultrastructural changes

• Single-cell analysis methodologies:

  • Investigate cell-to-cell variability in phosphorylation responses

  • Develop flow cytometry or mass cytometry protocols for phospho-EPS15 detection

  • Combine with other markers to characterize heterogeneity in endocytic responses

• Therapeutic modulation strategies:

  • Develop peptide inhibitors based on the Tyr849 region to selectively modulate EGFR endocytosis

  • Screen for small molecules that specifically affect this phosphorylation event

  • Explore combinations with existing EGFR-targeted therapies